Volume: 71s1 - Number: - year 2000
OPEN SESSION
Chairperson: Professor Baohong Ji
Objectives of the meeting
Baohong Ji
DOI: 10.5935/0305-7518.20000058
PDF
Leprosy research and elimination
S. K. Noordeen
DOI: 10.5935/0305-7518.20000059
PDF
SESSSION II: PROPHYLAXIS
Chairperson: Dr S. K. Noordeen
Prophylaxis-scope and limitations
S. K. Noordeen
DOI: 10.5935/0305-7518.20000060
PDF
Leprosy chemoprophylaxis in Micronesia
C. Diletto and L. Blanc
DOI: 10.5935/0305-7518.20000061
PDF
Approaches to studying the transmission of Mycobacterium leprae
MILEP2 Study Group
DOI: 10.5935/0305-7518.20000062
PDF
Strategies for pro-active case-finding in leprosy control
P. R. Klatser
DOI: 10.5935/0305-7518.20000063
PDF
Chemoprophylaxis of leprosy in the Southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years
L. N. Nguyen, J. L. Cartel and J. H. Grosset
DOI: 10.5935/0305-7518.20000064
PDF
Chemoprophylaxis against leprosy: expectations and methodology of a trial
P. Vijayakumaran, P. Krishnamurthy, P. Rao and E. Declerq
DOI: 10.5935/0305-7518.20000065
PDF
SESSION III: IMMUNODIAGNOSIS
Chairperson: Professor Patrick Brennan
South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy
M. D. Gupte
DOI: 10.5935/0305-7518.20000066
PDF
Skin test development in leprosy: progress with first-generation skin test antigens, and an approach to the second generation
P. J. Brennan
DOI: 10.5935/0305-7518.20000067
PDF
Diagnostic assays for leprosy based on T-cell epitopes
H. M. Dockrell, S. Brahmbhatt, B. D. Robertson, S. Britton, U. Fruth, N. Gebre, M. Hunegnaw, R. Hussan, R. Manadhar, l. Murrillo, M. C. V. Pessolani, P. Roche, J. L. Salgado, E. Sampaio, F. Shahid, J. E. R. Thole and D. B. Young
DOI: 10.5935/0305-7518.20000068
PDF
Whole blood assays for interferon-γ: practicalities and potential for use as diagnostic tests in the field
H. M. Dockrell, G. F. Black, R. E. Weir and P. E. M. Fine
DOI: 10.5935/0305-7518.20000069
PDF
Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology
U. Sengupta
DOI: 10.5935/0305-7518.20000070
PDF
Use of a Mycobacterium leprae dipstick to classify patients with leprosy
P. R. Klatser
DOI: 10.5935/0305-7518.20000071
PDF
SESION IV: CHEMETHERAPY
Chairperson: Professor Jacques Grossep
A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue
S. Franzblau
DOI: 10.5935/0305-7518.20000072
PDF
Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy
M. D. Gupte
DOI: 10.5935/0305-7518.20000073
PDF
Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy
B. Ji and J. Grosset
DOI: 10.5935/0305-7518.20000074
PDF
Current World Health Organization-sponsored studies in the chemotherapy of leprosy
D. Daumerie
DOI: 10.5935/0305-7518.20000075
PDF
Dapsone resistance in Mycobacterium leprae
T. P. Gillis and D. L. Williams
DOI: 10.5935/0305-7518.20000076
PDF
Rapid detection of resistance to rifampicin in Mycobacterium leprae
P. W. Roche, N. Shrestha, A. Thomas, N. Honore and S. T. Cole
DOI: 10.5935/0305-7518.20000077
PDF
The new challenges for chemotherapy research
J. Grosset
DOI: 10.5935/0305-7518.20000078
PDF
SESSION V: REACTIONS AND NERVE DAMAGE
Chairperson: Professor W. Cairns S. Smith
The epidemiology of reactions and nerve damage
P. Saunderson
DOI: 10.5935/0305-7518.20000079
PDF
Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness
D. N. J. Lockwood
DOI: 10.5935/0305-7518.20000080
PDF
Role of granulysin in immunity to leprosy
M. T. Ochoa, S. Thoma-Uszynski, P. A. Sieling, S. Sabet, S. Cho, A. M. Krensky, A. Burdik, T. H. Rea and R. L. Modlin
DOI: 10.5935/0305-7518.20000081
PDF
Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions
G. Kaplan
DOI: 10.5935/0305-7518.20000082
PDF
The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy
E. Spierings, T. de Boer, L. Zulianello, T. H. M. Ottenhoff
DOI: 10.5935/0305-7518.20000083
PDF
Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum
I. Nath, N. Vemuri, A. L. Reddi, M. Bharadwaj, P. Brooks, M. J. Colston, R. S. Misra and V. Ramesh
DOI: 10.5935/0305-7518.20000084
PDF
Review of current research in the prevention of nerve damage in leprosy
W. C. S. Smith
DOI: 10.5935/0305-7518.20000085
PDF
Peripheral neuropathy in leprosy and its consequences
W. H. Van Brakel
DOI: 10.5935/0305-7518.20000086
PDF
Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNFα
E. N. Sarno, A. R. Santos, M. R. Jardim, P. N. Suffys, A. S. Almeida, J. A. C. Nery, l. M. M. Vieira and E. P. Sampaio
DOI: 10.5935/0305-7518.20000087
PDF
SESSION VI: BASIC RESEARCH AN PATHONOGENESIS
Chairperson: Dr M. J. Colston
Preliminary analysis of the genome sequence of Mycobacterium leprae
S. T. Cole, N. Honore and K. Eiglmeier
DOI: 10.5935/0305-7518.20000088
PDF
Molecular basis of the interaction of Mycobacterium leprae with peripheral nerve: implications for therapeutic strategies
A. Rambukkana
DOI: 10.5935/0305-7518.20000089
PDF
Exploitation of gene knockout mice models to study the pathogenesis of leprosy
J. Krahenbuhl and L. B. Adams
DOI: 10.5935/0305-7518.20000090
PDF
Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines
W. J. Britton, E. Martin, A. T. Kamath, K. D. Neupane and P. W. Roche
DOI: 10.5935/0305-7518.20000091
PDF
SESSION VII: PROMOTION OF LEPROSY RESEARCH
Chairperson: Professor Baohong Ji
Leprosy research-setting priorities and facilitating collaborations: a personal perspective
A. M. Ginsberg
DOI: 10.5935/0305-7518.20000092
PDF
Research component in the global alliance
B. Ji
DOI: 10.5935/0305-7518.20000093
PDF
CLOSING SESSION: RECOMMENDATIONS
Chairperson: Professor Baohong Ji
Recommendations
Jacques H. Grosset
DOI: 10.5935/0305-7518.20000094
PDF
